172 related articles for article (PubMed ID: 23314782)
1. Is β endorphin related to migraine headache and its relief?
Misra UK; Kalita J; Tripathi GM; Bhoi SK
Cephalalgia; 2013 Apr; 33(5):316-22. PubMed ID: 23314782
[TBL] [Abstract][Full Text] [Related]
2. Role of β endorphin in pain relief following high rate repetitive transcranial magnetic stimulation in migraine.
Misra UK; Kalita J; Tripathi G; Bhoi SK
Brain Stimul; 2017; 10(3):618-623. PubMed ID: 28274721
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Controlled Trial of High Rate rTMS Versus rTMS and Amitriptyline in Chronic Migraine.
Kalita J; Kumar S; Singh VK; Misra UK
Pain Physician; 2021 Sep; 24(6):E733-E741. PubMed ID: 34554691
[TBL] [Abstract][Full Text] [Related]
4. Long-term antalgic effects of repetitive transcranial magnetic stimulation of motor cortex and serum beta-endorphin in patients with phantom pain.
Ahmed MA; Mohamed SA; Sayed D
Neurol Res; 2011 Nov; 33(9):953-8. PubMed ID: 22080997
[TBL] [Abstract][Full Text] [Related]
5. Effect of high rate rTMS on somatosensory evoked potential in migraine.
Kalita J; Bhoi SK; Misra UK
Cephalalgia; 2017 Nov; 37(13):1222-1230. PubMed ID: 27780897
[TBL] [Abstract][Full Text] [Related]
6. High frequency repetitive transcranial magnetic stimulation (rTMS) is effective in migraine prophylaxis: an open labeled study.
Misra UK; Kalita J; Bhoi SK
Neurol Res; 2012 Jul; 34(6):547-51. PubMed ID: 22732675
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache.
Kalita J; Laskar S; Bhoi SK; Misra UK
J Neurol; 2016 Nov; 263(11):2238-2246. PubMed ID: 27541044
[TBL] [Abstract][Full Text] [Related]
8. Low-frequency rTMS of the vertex in the prophylactic treatment of migraine.
Teepker M; Hötzel J; Timmesfeld N; Reis J; Mylius V; Haag A; Oertel WH; Rosenow F; Schepelmann K
Cephalalgia; 2010 Feb; 30(2):137-44. PubMed ID: 19515124
[TBL] [Abstract][Full Text] [Related]
9. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
Young W; Shaw J; Bloom M; Gebeline-Myers C
Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
[TBL] [Abstract][Full Text] [Related]
10. High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study.
Misra UK; Kalita J; Bhoi SK
J Neurol; 2013 Nov; 260(11):2793-801. PubMed ID: 23963471
[TBL] [Abstract][Full Text] [Related]
11. Serum beta-endorphin increase after intravenous histamine treatment of chronic daily headache.
Anselmi B; Tarquini R; Panconesi A; de Leonardis V; Perfetto F; Piluso A; Naldi E; Tarquini B
Recenti Prog Med; 1997; 88(7-8):321-4. PubMed ID: 9270292
[TBL] [Abstract][Full Text] [Related]
12. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
13. [Plasma beta-endorphin and caffeine consumption in chronic hemicrania].
Pinessi L; Piazza D; Vaula G; Rainero I; De Gennaro T; Bergamasco B; Farri A
Minerva Med; 1990 Oct; 81(10):691-5. PubMed ID: 2234463
[TBL] [Abstract][Full Text] [Related]
14. Role of glutamate and its receptors in migraine with reference to amitriptyline and transcranial magnetic stimulation therapy.
Tripathi GM; Kalita J; Misra UK
Brain Res; 2018 Oct; 1696():31-37. PubMed ID: 29859974
[TBL] [Abstract][Full Text] [Related]
15. Induction of long-lasting changes of visual cortex excitability by five daily sessions of repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers and migraine patients.
Fumal A; Coppola G; Bohotin V; Gérardy PY; Seidel L; Donneau AF; Vandenheede M; Maertens de Noordhout A; Schoenen J
Cephalalgia; 2006 Feb; 26(2):143-9. PubMed ID: 16426268
[TBL] [Abstract][Full Text] [Related]
16. beta-endorphin in plasma and monocytes in juvenile headache.
Battistella PA; Bordin A; Cernetti R; Broetto S; Corrà S; Piva E; Plebani M
Headache; 1996 Feb; 36(2):91-4. PubMed ID: 8742680
[TBL] [Abstract][Full Text] [Related]
17. rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study.
Brighina F; Piazza A; Vitello G; Aloisio A; Palermo A; Daniele O; Fierro B
J Neurol Sci; 2004 Dec; 227(1):67-71. PubMed ID: 15546593
[TBL] [Abstract][Full Text] [Related]
18. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
19. [Beta-endorphin levels in patients with pain syndromes in the areas of the face and head].
Puzin MN; Bassalyk LS; Kushlinskiĭ NE; Rushanov MI; Grigorian IuA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):69-72. PubMed ID: 2532837
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
